Norihisa Nishimura

1.8k total citations
71 papers, 1.1k citations indexed

About

Norihisa Nishimura is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Norihisa Nishimura has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 36 papers in Hepatology and 20 papers in Surgery. Recurrent topics in Norihisa Nishimura's work include Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (20 papers) and Liver physiology and pathology (10 papers). Norihisa Nishimura is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (20 papers) and Liver physiology and pathology (10 papers). Norihisa Nishimura collaborates with scholars based in Japan, United States and Italy. Norihisa Nishimura's co-authors include Tadashi Namisaki, Hitoshi Yoshiji, Hideto Kawaratani, Kosuke Kaji, Mitsuteru Kitade, Kei Moriya, Akitoshi Shimazaki, Yoshiaki Azuma, Shinya Sato and Yoshiki Yamano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Norihisa Nishimura

65 papers receiving 1.1k citations

Peers

Norihisa Nishimura
Diletta Overi Italy
Feng Shen China
Rie Irie Japan
Takanori Ito Japan
Hyun Ju Kim South Korea
Carlos M. Rodríguez‐Ortigosa Spain
Bharath Nath United States
Miriam Boersema Netherlands
Jinzheng Li China
Kerstin Abshagen Germany
Diletta Overi Italy
Norihisa Nishimura
Citations per year, relative to Norihisa Nishimura Norihisa Nishimura (= 1×) peers Diletta Overi

Countries citing papers authored by Norihisa Nishimura

Since Specialization
Citations

This map shows the geographic impact of Norihisa Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihisa Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihisa Nishimura more than expected).

Fields of papers citing papers by Norihisa Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihisa Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihisa Nishimura. The network helps show where Norihisa Nishimura may publish in the future.

Co-authorship network of co-authors of Norihisa Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Norihisa Nishimura. A scholar is included among the top collaborators of Norihisa Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihisa Nishimura. Norihisa Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oyama, Masafumi, Tadashi Namisaki, Satoshi Iwai, et al.. (2025). Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD. International Journal of Molecular Sciences. 26(19). 9560–9560.
2.
Kubo, Takahiro, Norihisa Nishimura, Kosuke Kaji, et al.. (2024). Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International Journal of Molecular Sciences. 25(8). 4405–4405. 3 indexed citations
3.
Asada, Shohei, Kosuke Kaji, Norihisa Nishimura, et al.. (2024). Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats. Cells. 13(6). 538–538. 14 indexed citations
4.
5.
Moriya, Kei, Shinya Sato, Norihisa Nishimura, et al.. (2023). Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine. 12(13). 4463–4463. 2 indexed citations
6.
Takaya, Hiroaki, Tadashi Namisaki, Takahiro Kubo, et al.. (2023). The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology. 12(2). 164–164. 4 indexed citations
7.
Suzuki, Junya, Kosuke Kaji, Norihisa Nishimura, et al.. (2023). A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines. 11(5). 1295–1295. 5 indexed citations
8.
Kaji, Kosuke, Norihisa Nishimura, Takahiro Kubo, et al.. (2023). Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity. Cells. 12(5). 687–687. 16 indexed citations
9.
Tanaka, Misako, Takemi Akahane, Hideto Kawaratani, et al.. (2023). Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B. Hepatology Research. 54(3). 252–260. 1 indexed citations
10.
Fujinaga, Yukihisa, Tadashi Namisaki, Yuki Tsuji, et al.. (2022). Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis. International Journal of Molecular Sciences. 23(17). 9814–9814. 2 indexed citations
11.
Takaya, Hiroaki, Tadashi Namisaki, Shohei Asada, et al.. (2022). ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine. 11(7). 1835–1835. 7 indexed citations
12.
Takeda, Soichi, Tadashi Namisaki, Yuki Fujimoto, et al.. (2022). Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study. Anticancer Research. 42(11). 5465–5473. 6 indexed citations
13.
Kitagawa, Koh, Akira Mitoro, Takahiro Ozutsumi, et al.. (2021). Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study. Clinical Endoscopy. 55(3). 434–442. 4 indexed citations
14.
15.
Kaji, Kosuke, Norihisa Nishimura, Koji Ishida, et al.. (2021). The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. Cells. 10(3). 575–575. 23 indexed citations
16.
Nishimura, Norihisa, Kosuke Kaji, Koh Kitagawa, et al.. (2021). Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences. 22(13). 6921–6921. 30 indexed citations
17.
Fujinaga, Yukihisa, Hideto Kawaratani, Daisuke Kaya, et al.. (2020). Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(15). 5589–5589. 29 indexed citations
18.
Chen, Zhaochun, Ronald E. Engle, Chen‐Hsiang Shen, et al.. (2020). Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans. PLoS Pathogens. 16(8). e1008793–e1008793. 4 indexed citations
19.
Asada, Kiyoshi, Yosuke Aihara, Hiroaki Takaya, et al.. (2016). DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis. World Journal of Hepatology. 8(28). 1194–1194. 5 indexed citations
20.
Douhara, Akitoshi, Kei Moriya, Hitoshi Yoshiji, et al.. (2014). Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Molecular Medicine Reports. 11(3). 1693–1700. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diletta Overi Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Rie Irie Breakdown of academic impact, for papers by Takanori Ito Breakdown of academic impact, for papers by Hyun Ju Kim Breakdown of academic impact, for papers by Carlos M. Rodríguez‐Ortigosa Breakdown of academic impact, for papers by Bharath Nath Breakdown of academic impact, for papers by Miriam Boersema Breakdown of academic impact, for papers by Jinzheng Li Breakdown of academic impact, for papers by Kerstin Abshagen
Rankless by CCL
2026